Abstract
Inflammatory mediators play a major role in both the local burn wound and the systemic response to burn injury. Oxidant and arachidonic acid metabolites are involved in the initial burn edema process. The mediators as well as the cytokines released from activated macrophages also result in an early generalized inflammatory response. The later postburn hypermetabolism is initiated and perpetuated by these same mediators, especially the cytokines, tumor necrosis factor, interleukin-1, and interleukin-2. Circulating endotoxin from the wound or the gut also appears to be involved. The postburn septic response is now recognized to be the result of inflammation; infection is not necessary. Mediator induced priming of the inflammatory cells by the burn itself results in an exaggerated response to infection in the postburn period. Defining the specific mechanism of injury and mediators involved can result in a major improvement in burn care, especially since many mediator inhibitors are already available for clinical use. It is essential that the clinician understand this pharmacologic manipulation in order to be able to optimally utilize these future advances.
Résumé
Les médiateurs de l'inflammation jouent un rôle important dans la réponse locale et systémique des lésions par brûlures. Sont impliqués dans l'oedème réactionnel les oxydants et les métabolites de l'acide arachidonique. Les médiateurs ainsi que les cytokines libérés par les macrophages activés font petu-être partie d'une réponse inflammatoire généralisée. L'hyper métabolisme post-brûlure est provoqué et entretenu par ces mêmes médiateurs, surtout les cytokines TNF, IL-1, et IL-6. Les endotoxines circulantes provenant de la plaie ou du tube digestif peuvent être incriminées. La réponse post-brûlure septique est aussi maintenant reconnue comme étant une conséquence de l'inflammation, même en dehors de l'infection. La réaction inflammatoire cellulaire provoquée par les médiateurs résulte en une réaction exagérée à l'infection dans la période postopératoire immédiate. La définition des mécanismes spécifiques des lésions et médiateurs améliore les soins des brûlures, surtout depuis que beaucoup de médiateurs sont prêts à être utilisés en clinique. Il est essentiel que la médecin comprenne cette manipulation pharmacologique afin d'utiliser de façon optimale les progès à l'avenir.
Resumen
Los mediadores inflamatorios juegan un papel mayor tanto en los fenómenos pertinentes a la quemadura local como en los referentes a la respuesta sistémica a la lesión térmica. Los oxidantes y los metabolitos del ácido araquidónico están involucrados en el proceso inicial del edema de la quemadura. Los mediadores, así como las citocinas liberadas por los macrófagos activados, también resultan en una reacción inflamatoria generalizada precoz. El hipermetabolismo tardío de la quemadura es iniciado y perpetuado por estos mismos mediadores, especialmente las citocinas, factor necrotizante tumoral, interleucina-1 e interleucina-6. La endotoxina circulante proveniente de la quemadura o del intestino también parece estar involucrada. La respuesta séptica también se roconoce ahora como resultante de la inflamación, sin que sea necesaro que existe infección. La activación de las células inflamatorias por los mediadores resulta en una exagerada respuesta a la infección del período postquemadura. La definición de los mecanismos específicos de la lesión y de los mediadores involucrados puede resultar en avance mayor en el tratamiento de la quemaduras, especialmente teniendo en cuenta que muchos inhibidores de mediadores ya se encuentran disponibles para uso clínico. Aparece esencial que el médico comprenda esta manipulación farmacológica para que sea capaz de utilizar en forma óptima los avances que se logren en al futuro.
Similar content being viewed by others
References
Nuytinck, H., Offerman, W., Goris, R.J.: Whole body inflammation in trauma patients. Arch Surg.123:1519, 1988
Goris, R.J., Boekhorst, T., Nuytinck, J.: Multiple organ failure: Generalized autodestructive inflammation. Arch. Surg.120:1109, 1985
Demling, R., LaLonde, C.: Early post burn lipid peroxidation: Effect of ibuprofen and allopurinol. Surgery107:85, 1990
Oldham, K., Guice, K., Till, G., Ward, P.: Activation of complement by hydroxyl radical thermal injury. Surgery104:272, 1988
Wilmore, D., Orcutt, T., Mason, A.: Alterations in hypothalamic function following thermal injury. J. Trauma15:697, 1975
Nerlich, M., Flynn, J., Demling, R.: Effect of thermal injury on endotoxin induced lung injury. Surgery92:289, 1983
Munster, A., Winchurch, R., Thupari, J., Ernst, C.B.: Reversal of post burn immunosuppression with low dose Polymyxin B. J. Trauma26:995, 1986
Demling, R., LaLonde, C.: Early burn excision attenuates the post burn lung and systemic response to endotoxin. Surgery (in press)
Demling, R., LaLonde, C.: Effect of partial burn excision and closure on post burn oxygen consumption. Surgery104:846, 1988
Schirmer, W., Schirmer, J., Townsend, M., Fry, D.: Femur fracture with associated soft tissue injury produced hepatic ischemia: Possible cause of hepatic dysfunction. Arch. Surg.123:412, 1988
Klebanoff, S., Vades, A., Harlan, L., Sparks, L.H., Gamble, J.R., Agosti, J.M., Waltersdorph, A.M.: Stimulation of neutrophils by tumor necrosis factor. J. Immunol.136:4220, 1986
Michie, H., Wilmore, D.: Sepsis, signals, and surgical sequelae: A hypothesis. Arch. Surg.125:531, 1990
Fong, Y., Moldawer, L., Shires, G.: The biologic characteristics of cytokines and their implication in surgical injury. Surg. Gynecol. Obstet.170:363, 1990
Michalek, S., Moore, R., MeGhee, J., Rosenstretch, D.L., Margenhogen, S.E.: The primary role of lymphoreticular cells in the mediation of host responses to bacterial endotoxin. J. Infect. Dis.141:55, 1980
Hesse, D., Tracey, K., Fong, Y., Manogue, K.R., Palladino, M.A. Jr., Cerami, A., Shires, G. T., Lowry, S. F.: Cytokine appearance in human endotoxemia. Surg. Gynecol. Obstet.166:147, 1988
Marano, M., Fong, Y., Moldawer, L., Wei, H., Calvano, S.E., Tracey, K.J., Barie, P.S., Manogue, K., Cerami, A., Shires, G.T.: Serum cachectin/tumor necrosis factor in critically ill patients with burns correlates with infection and mortality. Surg. Gynecol. Obstet.170:32, 1990
Debets, J., Kampmeyer, R., Mariello, P., Van Der Linden, M.P., Buurman, W.A.: Plasma tumor necrosis factor and mortality in critically ill septic patients. Crit. Care Med.17:489, 1989
Michie, H., Spriggs, D., Manogue, K., Wilmore, D.: Tumor necrosis factor and endotoxin induce similar metabolic responses in human beings. Surgery104:280, 1988
Beutler, B., Cerami, A.: Cachectin: More than tumor necrosis factor. N. Engl. J. Med.316:379, 1987
Kettehut, I., Frers, W., Goldberg, A.: The toxic effects of tumor necrosis factor in vivo and then prevention by cyclooxygenase inhibitors. Proc. Natl. Acad. Sci. U.S.A.84:4273, 1987
Dubravec, D., Saporoschetz, I., Collins, K., Mannick, J., Rodrick, M.: Polymorphonuclear neutrophils: Potential role in cytokine response to injury and infection. Surg. Forum41:112, 1990
Tracey, K., Fong, Y., Hesse, D., Manogue, K.R., Lee, A.T., Kuo, G.C., Lowry, S.F., Cerami, A.: Anti-cachetin/TNF monoclonal antibodies prevent septic shock during lethal bacteremia. Nature330:662, 1987
Tracey, K., Beutler, B., Lowry, S., Merryweather, J., Wolpe, S., Milsark, I.W., Hariri, R.J., Fahey, T.J., Zentella, A., Albert, J.D.: Shock and tissue injury induced by recombinant human cachectin. Science234:470, 1986
Revhaug, A., Michie, H., Manson, J., Wilmore, D.: Inhibition of cyclooxygenase attenuates the metabolic response to endotoxin in humans. Arch. Surg.123:162, 1988
Marano, M., Moldawer, L., Fong, Y., Wei, H., Minei, J., Yurt, R., Cerami, A., Lowry, S.F.: Cachectin tumor necrosis factor production in experimental burns and pseudomonas infection. Arch. Surg. (in press)
Meyer, J., Yurt, R., Duhaney, R., Jesse, D.G., Tracey, K.J., Fong, Y.M., Verma, M., Shires, G.T., Dineen, P., Lowry, S.F.: Tumor necrosis factor enhanced leukotriene B4 generation and chemotaxis in human neutrophils. Arch. Surg.123:1454, 1988
Dinarello, C.: Biology of interleukin-1. FASEB J.2:108, 1988
Okusawa, S., Gelford, J., Ikejima, T., Connolly, R.J., Dinarello, C.A.: Interleukin-1 induces a shock like state in rabbits: Synergism with TNF and the effects of cyclooxygenase inhibition. J. Clin. Invest.81:1162, 1988
Teodorczyk-Injeyan, J., Sparkes, B., Mills, G., Peters, W.J., Falk, R.E.: Impairment of T cell activation in burn patients: A possible mechanism of thermal injury induced immunosuppression. Clin. Exp. Immunol.65:570, 1986
Choucrib, S., Chatenoud, L., Klatzmann, D., Fradelizi, D.: The mechanism of inhibition of human IL-2 production: PGE2 induction of suppression T lymphocytes. J. Immunol.132:1851, 1984
Wood, J., Roderick, M., O'Mahoney, J., Mannick, J.A.: Inadequate interleukin-2 production: A fundamental immunological deficiency in patients with major burns. Ann. Surg.200:311, 1984
Roderick, M., Saporoschetz, I., Wood, J., Davis, C., Mannick, J.: Serum suppression of interleukin-2 (IL-2) production and IL-2 action in thermal injury. Surg. Forum40:98, 1989
Gaugh, D., Moss, N., Jordan, A., Grbic, J., Roderick, M., Mannick, J.: Recombinant interleukin-2 improves immune response and host resistance to septic challenge in thermally injured mice. Surgery104:292, 1988
Guang-xia, X., Chopra, R., Adler, W., Munster, A., Winchurch, R.: Altered expression of lymphocyte IL-2 receptors in burned patients. J. Trauma28:1669, 1988
Michie, H., Eberlein, T., Spriggs, D.R., Manogue, K.R., Cerami, A., Wilmore, D.W.: Interleukin-2 initiates metabolic responses associated with critical illness in humans. Ann. Surg.208:493, 1988
Tosato, C., Seamon, K.B., Goldman, N.D., Sehgal, P.B., May, L.T., Washington, G.C., Jones, K.D., Pike, S.E.: Monocyte derived humanβ-cell growth factor identified as interferon-B2 (BSF-2, IL-6). Science239:502, 1988
Cicco, N.A., Lindemann, A., Content, J., Vandenbussche, P., Lubbert, M., Gauss, J., Mertelsmann, R., Herrmann, F.: Inducible production of interleukin-6 by human polymorphonuclear neutrophils: Role of granulocyte macrophage colony stimulating factor and tumor necrosis factor-alpha. Blood75:2049, 1990
Guo, Y, Dickinson, C., Chrest, F., Adler, W.H. Munster, A.M., Winchurch, R.A.: Increased levels of circulating interleukin-6 in burn patients. Clin. Immunol. Immunopathol.54:361, 1990
Nathan, C., Murray, F., Wiebe, W., Rubin, B.: Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and anti-microbial activity. J. Exp. Med.158:670, 1983
Wilson, C., Westall, J.: Activation of neonatal and adult human macrophages by alpha, beta, and gamma interferons. Infect. Immun.49:351, 1985
Mooney, D., Gamelli, R., O'Reilly, M., Hebert, J.: Recombinant human granulocyte colony stimulating factor and pseudomonas burn wound sepsis. Arch. Surg.123:1353, 1988
Winchurch, R., Thupari, J., Munster, Al: Endotoxemia in burn patients: Levels of circulating endotoxins are related to burn size. Surgery102:808, 1987
Crowley, B., O'Riordan, M., Ellwanger, K.: Anti-endotoxin therapy improves survival in a model of thermal injury and sepsis. Surg. Forum41:72, 1990
Halliwell, B.: Oxidants and human disease: Some new concepts. FASEB J.1:358, 1987
Halliwell, B., Gutteridge, J.: Oxygen free radicals and iron in relation in biology and medicine: Some problems and concepts. Arch. Biochem. Biophys.246:501, 1986
Friedl, H., Till, G., Trentz, O., Ward, P.: Roles of histamine complement and xanthine oxidase in thermal injury. Am. J. Pathol.135:203, 1989
Sasaki, J., Cottam, G., Baxter, C.: Lipid peroxidation following thermal injury. J. Burn Care Rehabil.4:251, 1987
Friedl, H., Till, G., Ryan, U., Ward, P.: Mediator induced activation of xanthine oxidase in endothelial cells. FASEB J.3:2512, 1989
Demling, R., LaLonde, C., Knox, J., Youn, Y.K.: Fluid resuscitation with deferoxamine prevents systemic burn induced oxidant injury. J. Trauma (in press)
Demling, R., LaLonde, C., Seekamp, A., Fiore, N.: Endotoxin causes hydrogen peroxide induced lung lipid peroxidation and prostanoid production. Arch. Surg.123:1337, 1988
Seekamp, A., LaLonde, C., Zhu, D., Demling, R.: Catalase prevents prostanoid release and lung lipid peroxidation after endotoxemia in unanesthetized sheep. J. Appl. Physiol.65:1210, 1988
Aoki, N., Lefer, A.: Protective effects of a novel nonglucocorticoid 21-aminosteroid U74006F during traumatic shock in rats. J. Cardiovasc. Pharmacol.15:202, 1990
Harms, B., Bodai, B., Demling, R.: Prostaglandin release and altered microvascular integrity after burn injury. J. Surg. Res.31:272, 1981
Jin, L., LaLonde, C., Demling, R.: Lung dysfunction after thermal injury: Relationship to prostanoid and oxygen radical release. J. Appl. Physiol.61:103, 1986
DelBeccaro, E., Robson, M., Heggars, J., Swaminathan, R.: The use of specific thromboxane inhibitors to pressure the dermal microcirculation after burning. Surgery87:137, 1980
Demling, R., LaLonde, C.: Topical ibuprofen decreases early post burn edema. Surgery102:857, 1987
Alvarez, O., Levendorf, K., Smerbeck, R., Mertz, P.M., Eaglstein, W.H.: Effect of topically applied steroidal and nonsteroidal anti-inflammatory agents on skin repair and regeneration. Fed. Proc.43:2793, 1984
Hansborough, J., Peterson, V., Zapata-Servent, R., Claman, H.: Post burn immunosuppression in an animal model: Restoration of cell mediated immunity by immunomodulating drugs. Surgery93:290, 1984
LaLonde, C., Knox, J., Daryani, R., Zhu, D., Demling, R.H.: Topical flurbiprofen decreases burn wound induced hypermetabolism and systemic lipid peroxidation. Surgery (in press)
Demling, R., Smith, M., Gunther, R., Flynn, J., Gee, M.: Pulmonary injury and prostaglandin production during endotoxemia in conscious sheep. Am. J. Physiol.240:348, 1981
Bernard, G., Reines, H., Metz, C., Halushka, P., Swindell, B., Higgins, S., Wright, P., Watts, F.: Effects of a short course of ibuprofen in patients with severe sepsis. Am. Rev. Respir. Dis.134:138, 1988
Katz, A., Ryan, P., LaLonde, C., Demling, R.: Topical ibuprofen decreases thromboxane release from the endotoxin stimulated burn wound. J. Trauma26:157, 1986
Lewis, R., Austen, F., Soberman, R.: Leukotrienes and other products of the 5-lipoxygenase pathway. N. Engl. J. Med.323:645, 1990
Koller, M., Konig, W., Brom, J., Raulf, M. Muller, F.: Generation of leukotrienes from human polymorphonuclear granulocytes of severely burned patients. J. Trauma28:733, 1988
Dobke, M., Hayes, E., Baxter, C.: Leukotrienes LTB4 and LTC4 in thermally injured patients' plasma and burn blister fluid. JBCR8:189, 1987
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Youn, YK., LaLonde, C. & Demling, R. The role of mediators in the response to thermal injury. World J. Surg. 16, 30–36 (1992). https://doi.org/10.1007/BF02067111
Issue Date:
DOI: https://doi.org/10.1007/BF02067111